Lawrence Waldman - Jul 12, 2023 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Lawrence Waldman
Stock symbol
APYX
Transactions as of
Jul 12, 2023
Transactions value $
$15,854
Form type
4
Date filed
7/19/2023, 12:00 PM
Previous filing
Aug 18, 2022
Next filing
Jul 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $15.9K +5.34K $2.97 5.34K Jul 12, 2023 By SLAT F1, F2, F3
holding APYX Common Stock 37.6K Jul 12, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Options Exercise $0 -12K -100% $0.00* 0 Jul 12, 2023 Common Stock 12K $2.97 By SLAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock.
F2 The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT.
F3 The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.